ArticleJournal of clinical medicine2020

Association between the Use of Dipeptidyl Peptidase 4 Inhibitors and the Risk of Dementia among Patients with Type 2 Diabetes in Taiwan.

Kuan-Chan Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.